1. Home
  2. PET vs PHGE Comparison

PET vs PHGE Comparison

Compare PET & PHGE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PET
  • PHGE
  • Stock Information
  • Founded
  • PET 2015
  • PHGE 2015
  • Country
  • PET United States
  • PHGE Israel
  • Employees
  • PET N/A
  • PHGE N/A
  • Industry
  • PET EDP Services
  • PHGE Biotechnology: Pharmaceutical Preparations
  • Sector
  • PET Technology
  • PHGE Health Care
  • Exchange
  • PET Nasdaq
  • PHGE Nasdaq
  • Market Cap
  • PET 10.7M
  • PHGE 11.1M
  • IPO Year
  • PET N/A
  • PHGE N/A
  • Fundamental
  • Price
  • PET $0.22
  • PHGE $0.62
  • Analyst Decision
  • PET Strong Buy
  • PHGE Strong Buy
  • Analyst Count
  • PET 5
  • PHGE 2
  • Target Price
  • PET $4.40
  • PHGE $22.50
  • AVG Volume (30 Days)
  • PET 1.8M
  • PHGE 72.5K
  • Earning Date
  • PET 02-12-2025
  • PHGE 11-14-2024
  • Dividend Yield
  • PET N/A
  • PHGE N/A
  • EPS Growth
  • PET N/A
  • PHGE N/A
  • EPS
  • PET N/A
  • PHGE N/A
  • Revenue
  • PET $76,747,000.00
  • PHGE N/A
  • Revenue This Year
  • PET N/A
  • PHGE N/A
  • Revenue Next Year
  • PET $13.90
  • PHGE N/A
  • P/E Ratio
  • PET N/A
  • PHGE N/A
  • Revenue Growth
  • PET N/A
  • PHGE N/A
  • 52 Week Low
  • PET $0.14
  • PHGE $0.48
  • 52 Week High
  • PET $2.47
  • PHGE $8.55
  • Technical
  • Relative Strength Index (RSI)
  • PET 35.66
  • PHGE 45.57
  • Support Level
  • PET $0.20
  • PHGE $0.56
  • Resistance Level
  • PET $0.24
  • PHGE $0.69
  • Average True Range (ATR)
  • PET 0.02
  • PHGE 0.08
  • MACD
  • PET 0.02
  • PHGE 0.01
  • Stochastic Oscillator
  • PET 42.62
  • PHGE 28.57

About PET Wag! Group Co.

Wag Group Co develops and supports a proprietary marketplace technology platform available as a website and mobile app that enables independent Pet Caregivers to connect with pet parents. The platform allows pet parents to make pet service requests in the platform, which can then be fulfilled by Pet Caregivers. Wag supports dog walking, pet sitting, pet boarding, drop-in visits at the pet parent's home, advice from licensed pet experts, training services, pet insurance comparison tools, and pet wellness plans.

About PHGE BiomX Inc. COmmon Stock

BiomX Inc is a clinical-stage microbiome company based in Israel. The company is engaged in developing both natural and engineered phage cocktails designed to target and destroy harmful bacteria that affect the appearance of the skin, as well as harmful bacteria in chronic diseases, such as inflammatory bowel disease, colorectal cancer, and primary sclerosing cholangitis. BX004 is its therapeutic phage product candidate under development for chronic pulmonary infections caused by Pseudomonas aeruginosa, or P. aeruginosa, a main contributor to morbidity and mortality in patients with CF.

Share on Social Networks: